RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial.

Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial.

Add to Collection
2011 Aug 6 RCTs N Sherry, W Hagopian, J Ludvigsson, SM Jain… - The Lancet, 2011 - thelancet.com

Full Author : ['Sherry, Nicole', 'Hagopian, William', 'Ludvigsson, Johnny', 'Jain, Sunil M', 'Wahlen, Jack', 'Ferry, Robert J Jr', 'Bode, Bruce', 'Aronoff, Stephen', 'Holland, Christopher', 'Carlin, David', 'King, Karen L', 'Wilder, Ronald L', 'Pillemer, Stanley', 'Bonvini, Ezio', 'Johnson, Syd', 'Stein, Kathryn E', 'Koenig, Scott', 'Herold, Kevan C', 'Daifotis, Anastasia G']
Journal Title : Lancet (London, England)
Chapter : Section5
Journal Year : 2011
Cited by : 504

BACKGROUND: Findings of small studies have suggested that short treatments with anti-CD3 monoclonal antibodies that are mutated to reduce Fc receptor binding preserve beta-cell function and decrease insulin needs in patients with recent-onset type 1 diabe..... Read More

Keywords : ['type diabete protege study result', 'randomise placebocontrolle trial', 'treatment', 'teplizumab']
PubMed Link : https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(11)60931-8/fulltext
Google Scholar Link : https://scholar.google.com/scholar?cites=8347948246549621612&as_sdt=5,33&sciodt=0,33&hl=en&num=20